Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Observation of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Population Aged 3~17 Years : A Multicenter,Open-label Study

NCT04992208 is registered in ClinicalTrials.gov with Sinovac Life Sciences Co., Ltd. as lead sponsor.

NCT NCT04992208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04992208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Observation of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Population Aged 3~17 Years : A Multicenter,Open-label Study
Lead sponsor
Sinovac Life Sciences Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
July 24, 2021
Completion date
August 31, 2023
Enrollment
31,041 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19